Spatiotemporally programmable surface engineered nanoparticles for effective anticancer drug delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery

Background:

• Developing targeted drug delivery systems is crucial for improving therapeutic efficacy and reducing side effects.
• Nanoparticles offer a promising platform for drug delivery due to their tunable properties and ability to encapsulate various therapeutic agents.

Purpose of the Study:

• To fabricate and characterize novel surface-engineered nanoparticles (NPs) for enhanced tumor-specific drug delivery.
• To evaluate the potential of these NPs for delivering hydrophobic drugs to tumor cells.

Main Methods:

• Fabrication of core-shell nanoparticles using polycaprolactone-polyethylenimine-folic acid (PCL-PEI-FA) and polycaprolactone-S-S-polyethylene glycol (PCL-S-S-PEG) copolymers.
• Characterization of nanoparticle size and structure using Field Emission Scanning Electron Microscopy (FESEM).
• In vitro assessment of nanoparticle endocytosis and cytotoxicity in cell lines.

Main Results:

• FESEM confirmed the core-shell structure of the NPs with a size of approximately 230 nm.
• The NPs possess a stealthy nature and specific targeting capability due to PEG and folic acid functionalization.
• Disulfide bonds in PCL-S-S-PEG enable reduction-induced degradation.
• Enhanced endocytosis and cytotoxicity were observed in cell line experiments.

Conclusions:

• PCL-PEI-FA/PCL-S-S-PEG NPs demonstrate potential as an effective system for tumor-specific delivery of hydrophobic drugs.
• The combination of targeting ligands, stealth polymers, and reducible linkers offers a promising strategy for advanced cancer therapy.